Post by Alira Health

Patient involvement can no longer be viewed as a purely national activity for health technologies that fall under JCA. Companies should plan when and how patient input will be used across EU joint work, while still recognizing that part of the HTA process will remain in the hands of Member States. ⬇️ The article below outlines where patient involvement fits within JSC and JCA, what will continue to happen at a national level, and how health technology developers can prepare for a more coordinated approach to patient engagement under EU HTA.